Why kinetic folding matters in RNA design

RNA design is incomplete when equilibrium structure is treated as the sole criterion. Folding kinetics becomes essential whenever pathway, timing, or metastable intermediates contribute to function.

RNA design is frequently formulated as a problem of specifying a target structure and identifying sequences that adopt this structure with high thermodynamic stability. In many cases, this is a useful and necessary starting point. However, it is not a complete description of function. Many RNAs are not defined only by their equilibrium structure, but by the pathway through which this structure is reached. Both the time at which a functional conformation becomes available, and the persistence of metastable states can become integral determinants of RNA stability.

Kinetic folding therefore becomes important whenever the route (often referred to as folding path) to a structure contributes to the mechanism. Equilibrium thermodynamics describes the relative stability of states. It does not, by itself, describe whether a transcript can reach a productive state within the relevant time frame, whether a competing structure blocks this route, or whether cotranscriptional folding traps the molecule before the intended conformation becomes accessible.

This distinction has been central to several earlier studies. The post Folding kinetics of large RNAs discusses why pathway information becomes increasingly important for RNA systems that extend beyond small model examples. Likewise, BarMap: RNA folding on dynamic energy landscapes emphasizes that the folding landscape is not fixed during transcription, but changes as the nascent RNA chain grows. This becomes particularly relevant in Efficient computation of cotranscriptional RNA-ligand interaction dynamics, where ligand binding must be considered together with the transient formation of binding-competent intermediates.

For synthetic RNA design, these issues are especially relevant for switches, aptamer-coupled systems, regulatory elements, and other constructs in which timing is part of the functional mechanism. A candidate sequence may satisfy all static structural constraints and nevertheless fail experimentally. The active conformation may form too late, a competing helix may sequester essential nucleotides, or the ligand-binding state may exist only outside the relevant temporal window. In such cases, the design has not failed because the target structure was incorrectly specified, but because the design objective did not sufficiently represent the mechanism.

The same principle applies from the design perspective in In silico design of ligand-triggered RNA switches. A meaningful objective function must encode the intended functional logic, not merely a desired endpoint structure. Once this objective is formulated in mechanistic terms, kinetic information becomes a design criterion rather than a post hoc explanation for failure.

Recent work on KinPFN: Bayesian Approximation of RNA Folding Kinetics and Bayesian Approximation of RNA Folding Times addresses a practical limitation that has long constrained this area. Detailed kinetic simulations can be highly informative, but their computational cost limits their routine use in large design spaces. Approximation methods are valuable because they allow folding-time information to be incorporated earlier in the design process, where many alternative sequences still have to be compared.

The central methodological risk is therefore clear. RNA design can optimize the wrong criterion. If function depends on pathway behaviour, then a convincing equilibrium fold may still be insufficient. Kinetic reasoning does not replace thermodynamic design, comparative analysis, or experimental validation. Instead, it adds a necessary layer of interpretation whenever timing, accessibility, or transient states are part of the mechanism.

This becomes particularly important when candidate designs have to be prioritized before experimental resources are committed. At this stage, a project may already have plausible sequences, an assay strategy, and a mechanistic hypothesis, but still lack a clear distinction between a folding-pathway problem, a sequence-design problem, and a measurement problem. A structured review can help clarify this distinction and identify which candidates are most informative to test next. My services page describes how I approach design reviews and advisory work for teams facing this type of decision.